[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aclarion Inc (ACON)

Aclarion Inc (ACON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aclarion Inc 8181 Arista Place Suite 100 Broomfield CO 80021 USA

www.aclarion.com Employees: 11 P: 833-275-2266

Sector:

Medical

Description:

Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA.

Key Statistics

Overview:

Market Capitalization, $K 7,842
Enterprise Value, $K -4,198
Shares Outstanding, K 2,462
Float, K 2,443
% Float 99.23%
Short Interest, K 198
Short Float 8.04%
Days to Cover 1.51
Short Volume Ratio 0.70
% of Insider Shareholders 0.77%
% of Institutional Shareholders 7.52%

Financials:

Annual Sales, $ 80 K
Annual Net Income, $ -7,230 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -1,890 K
EBIT, $ -7,050 K
EBITDA, $ -6,820 K

Growth:

1-Year Return -53.50%
3-Year Return -100.00%
5-Year Return 0.00%
5-Year Revenue Growth 60.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.01 on 03/18/26
Next Earnings Date 05/21/26 [--]
Earnings Per Share ttm -17.01
EPS Growth vs. Prev Qtr 31.40%
EPS Growth vs. Prev Year -99.77%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-27 on 03/28/25

ACON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -52.31%
Return-on-Assets % -49.79%
Profit Margin % -9,037.50%
Debt/Equity 0.00
Price/Sales 102.38
Price/Cash Flow N/A
Price/Book 0.21
Book Value/Share 15.11
Interest Coverage -0.20
60-Month Beta 1.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.